Profile data is unavailable for this security.
About the company
ProSomnus, Inc. is a medical technology company. The Company is focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Its intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. The Company's devices have demonstrated efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. Its precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide.
- Revenue in USD (TTM)29.30m
- Net income in USD-18.69m
- Incorporated2022
- Employees136.00
- LocationProsomnus Inc5675 Gibraltar DrPLEASANTON 94588United StatesUSA
- Fax+1 (302) 636-5454
- Websitehttps://prosomnus.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellness Center USA Inc | 391.23k | -1.19m | 57.80k | 4.00 | -- | -- | -- | 0.1477 | -0.0092 | -0.0092 | 0.0031 | -0.0249 | 2.23 | 1.10 | -- | -- | -892.24 | -2,092.00 | -- | -- | 67.81 | 37.82 | -399.36 | -1,462.73 | 0.011 | -1.95 | -- | -- | 4,699.20 | -4.34 | 63.70 | -- | -- | -- |
| Prosomnus Inc | 29.30m | -18.69m | 69.58k | 136.00 | -- | -- | -- | 0.0024 | -1.15 | -1.15 | 1.70 | -1.31 | 1.12 | 10.58 | 8.37 | 215,453.20 | -52.46 | -- | -458.34 | -- | 49.77 | -- | -46.97 | -- | 0.2471 | -3.00 | 3.82 | -- | 42.59 | -- | -237.21 | -- | -- | -- |
| G Medical Innovations Holdings Ltd | -100.00bn | -100.00bn | 229.95k | -- | -- | 0.0011 | -- | -- | -- | -- | -- | 8.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.52 | -- | 0.306 | -- | 80.47 | -- | 7.68 | -- | -- | -- |
| Motus GI Holdings Inc | 327.00k | -16.10m | 236.52k | 15.00 | -- | 0.0697 | -- | 0.7233 | -12.68 | -12.68 | 0.1134 | 0.5886 | 0.0339 | 1.18 | 4.92 | 21,800.00 | -109.80 | -80.63 | -182.50 | -112.32 | -24.46 | -44.53 | -3,239.76 | -6,160.58 | 1.67 | -13.01 | 0.4287 | -- | -46.11 | 54.70 | 30.81 | -- | -28.25 | -- |
| Electromedical Technologies Inc | 1.26m | -3.02m | 339.67k | 6.00 | -- | -- | -- | 0.2695 | -0.0077 | -0.0077 | 0.0029 | -0.0076 | 1.11 | 2.80 | 270.18 | 210,066.70 | -265.30 | -340.23 | -- | -- | 77.11 | 75.94 | -239.72 | -406.26 | 0.0899 | -0.5008 | -- | -- | 17.30 | 14.84 | 26.05 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Forbes Financial Planning, Inc.as of 31 Mar 2024 | 465.71k | 2.68% |
| Wells Fargo Advisors Financial Network LLCas of 31 Mar 2024 | 116.95k | 0.67% |
| LPWM LLCas of 31 Mar 2024 | 67.27k | 0.39% |
| Tradition Wealth Management LLCas of 31 Mar 2024 | 50.00k | 0.29% |
| Bridgeway Capital Management LLCas of 31 Mar 2024 | 50.00k | 0.29% |
| Periscope Capital, Inc.as of 31 Mar 2024 | 26.00k | 0.15% |
| Presidio Capital Management LLCas of 31 Mar 2024 | 20.00k | 0.12% |
| Vanguard Personalized Indexing Management LLCas of 31 Mar 2024 | 15.66k | 0.09% |
| HBK Sorce Advisory LLCas of 31 Mar 2024 | 15.41k | 0.09% |
| Garden State Investment Advisory Services LLCas of 31 Mar 2024 | 15.37k | 0.09% |
